http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102157043-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-867 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742 |
filingDate | 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102157043-B1 |
titleOfInvention | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using bacillus coagulans sbc37-01, mtcc 5856 |
abstract | The present invention relates to the treatment of diarrhea predominant irritable bowel syndrome in humans comprising oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing at least 2 billion spores), with standard treatment of management in a specific manner. It shows the method for management. |
priorityDate | 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.